ELISA CASEY: Open Payments
NPI 1154313138 · TALLAHASSEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$652 in 35 payments from 12 companies in 2025. Trend: 2023 $1,340 · 2024 $1,293 · 2025 $652
Food & beverage: $652
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $207 |
| Lilly USA, LLC | 4 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $73 |
| Indivior Inc. | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $49 |
| Exact Sciences Corporation | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| UCB, Inc. | 1 | $31 |
| Novo Nordisk Inc | 2 | $28 |
| BETA BIONICS, INC. | 1 | $25 |
Products named: UBRELVY, CAPLYTA, MOUNJARO, QULIPTA, SUBLOCADE, Kerendia, VRAYLAR, The Cologuard Plus Collection Kit.
Industry payments across FL — which companies pay providers there.
